SciSparc Announces Transformation into Agentic AI-Powered Technologies, Including Cybersecurity and Finance Technologies
October 15, 2026
INmune Bio, Inc. to Present at the Canaccord Genuity 41st Annual Growth Conference
August 10, 2021
Related Post
-
-
NervGen Announces First Participant Dosed in RESTORE, a Phase 3 Registrational Study Evaluating NVG-291 in Chronic Spinal Cord Injury
October 12, 2026
-
X4 Pharmaceuticals Secures Up to $150 Million Senior Debt Facility with K2 HealthVentures
October 8, 2026
-
Nutriband Files New Patent Application to Strengthen Intellectual Property Protection of Its Transdermal Abuse Deterrent Technology
October 8, 2026